Stocktoria

Indaptus Therapeutics, Inc. INDP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-09-07

Indaptus Therapeutics, Inc. statistics & valuation

Market cap$386.2M
Return on capital-629.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-21.50% -58.20% -127.70% -380.80% -661.50% 202020212022202320242025
Shares outstanding
1.9M 8.3M 8.4M 8.4M 428799 2.2M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-201.60% -19.00% -51.00% -103.30% -204.70% -223.90% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$1.73 -$1.83 -$44.96 -$21.58 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-223.9%-204.7%-103.3%-51.0%-19.0%-201.6%
Return on equity-661.5%-380.8%-127.7%-58.2%-21.5%1507.8%
Current ratio1.511.955.057.948.770.86

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.